LMB

Limbach Holdings, Inc. Industrials Construction - Special Trade Contractors Russell 3000
$48.40Close $562.7MMarket cap $41.22 – $114.1152-week range Nov 3, 2026Next report · after the close

Highlights

Cautions

  • Not in an uptrend 0 of 8 trend conditions
  • Lagging the market RS 4 · weaker than 96% of stocks over 12 months
  • Far from its high 58% below its 52-week high
  • Earnings shrinking EPS −38% year on year
  • Results soon Nov 3, 2026, in 2 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 4, 2026
Off 12-month high 58%
1wk up 1.7% price change
1mo down 1.1% price change
12-month return down 50% market up 11% · its own down 60%
F-score 5 / 9 Mixed
Altman Z″ 3.87 Low risk
P/E 14.4× price / earnings
PEG 0.55 P/E / EPS growth
P/B 2.9× price / book
Earnings yield up 8.5% EBIT / enterprise value
Cheaper than 75% of the market · cheap
Revenue growth up 25% year on year
EPS growth down 38% latest quarter · +19 pts
Sales growth up 22% latest quarter · +18 pts
ROE up 22% return on equity
Free cash margin up 6% $41.9M FCF
D/E 0.16 long-term debt / equity
Net debt / EBITDA 0.3×
Interest cover —EBIT / interest
Piotroski tests
  • took on more long-term debt
  • short-term liquidity weakened
  • issued more shares
  • gross margin narrowed
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • assets working harder

Trade setup

ATR% 4.6% $2.25 a day · 2×ATR $43.90
RS 4 / 99 vs the universe
Trend 0 / 8 trend template
Relative volume 0.5× vs 50-day average
Up/down volume 1.42 50 sessions
Implied move — no option chain · report Nov 3, 2026
Trend template · 0 of 8

Screen verdict

Did not qualify for any screen.

Warning signs

2 flagged
  • Shareholders diluted The share count rose 3.1% over the year, from 11m to 12m shares. Each existing share owns a smaller fraction of the company than it did a year ago.
  • Gross margin narrowing Gross margin fell from 27.8% to 26.2%. The company is keeping less of each dollar of sales than it did a year ago.
Last reported Aug 4, 2026
Last shock Aug 5, 2026-36% in one session6.6× volumeon results-3% since

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $646.8M +25% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $568.2M FY2021 · $490.4M FY2022 · $496.8M FY2023 · $516.4M FY2024 · $518.8M FY2025 · $646.8M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $39.1M +27% on FY2024
$0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $5.8M FY2021 · $6.7M FY2022 · $6.8M FY2023 · $20.8M FY2024 · $30.9M FY2025 · $39.1M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $41.9M +43% on FY2024
-$50M $0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $38.3M FY2021 · -$25.0M FY2022 · $34.4M FY2023 · $55.1M FY2024 · $29.3M FY2025 · $41.9M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 26%
  • Net 6%
  • Free cash 6%
-10% 0% 50% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 14% · Net 1% · Free cash 7% FY2021 · Gross 18% · Net 1% · Free cash -5% FY2022 · Gross 19% · Net 1% · Free cash 7% FY2023 · Gross 23% · Net 4% · Free cash 11% FY2024 · Gross 28% · Net 6% · Free cash 6% FY2025 · Gross 26% · Net 6% · Free cash 6%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $19.2M net debt
  • Cash
  • Long-term debt
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $42.1M · Long-term debt $36.5M FY2021 · Cash $14.5M · Long-term debt $29.8M FY2022 · Cash $36.0M · Long-term debt $21.5M FY2023 · Cash $59.8M · Long-term debt $19.6M FY2024 · Cash $44.9M · Long-term debt $23.6M FY2025 · Cash $11.3M · Long-term debt $30.5M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 11.63m +46.7% since FY2020
11.63m 7.93m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 7.93m FY2021 · 10.30m FY2022 · 10.29m FY2023 · 11m FY2024 · 11.27m FY2025 · 11.63m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $568.2M $490.4M $496.8M $516.4M $518.8M $646.8M
Gross margin 14% 18% 19% 23% 28% 26%
Operating income $17.2M $14.0M $12.0M $29.3M $38.6M $49.5M
Net income $5.8M $6.7M $6.8M $20.8M $30.9M $39.1M
Net margin 1% 1% 1% 4% 6% 6%
Earnings per share $0.72 $0.66 $0.64 $1.76 $2.57 $3.23
Free cash flow $38.3M -$25.0M $34.4M $55.1M $29.3M $41.9M
Free cash margin 7% -5% 7% 11% 6% 6%
Cash $42.1M $14.5M $36.0M $59.8M $44.9M $11.3M
Long-term debt $36.5M $29.8M $21.5M $19.6M $23.6M $30.5M
Shareholders' equity $53.7M $87.8M $95.4M $120.9M $153.5M $195.7M
Shares outstanding 7.93m 10.30m 10.29m 11m 11.27m 11.63m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 4, 2026 Quarterly ↗ Jun 30, 2026 35d
May 5, 2026 Quarterly ↗ Mar 31, 2026 35d
Mar 2, 2026 Annual ↗ Dec 31, 2025 61d
Nov 4, 2025 Quarterly ↗ Sep 30, 2025 35d
Aug 5, 2025 Quarterly ↗ Jun 30, 2025 36d
May 5, 2025 Quarterly ↗ Mar 31, 2025 35d
Mar 10, 2025 Annual ↗ Dec 31, 2024 69d
Nov 5, 2024 Quarterly ↗ Sep 30, 2024 36d
Aug 6, 2024 Quarterly ↗ Jun 30, 2024 37d
May 8, 2024 Quarterly ↗ Mar 31, 2024 38d
Mar 13, 2024 Annual ↗ Dec 31, 2023 73d
Nov 8, 2023 Quarterly ↗ Sep 30, 2023 39d

Current reports